Efficacy of ixazomib for the treatment of relapsed/refractory multiple myeloma: A protocol of systematic review and meta-analysis

BACKGROUND: Over the past years, ixazomib has been increasingly explored for the treatment of relapsed/refractory multiple myeloma (RRMM). However, its results are still contradictory. This study will explore the efficacy and safety of ixazomib for patients with RRMM. METHODS: A systematic records s...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhi, Guo, Shu-Li, Wang, Wan-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
3700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253538/
https://www.ncbi.nlm.nih.gov/pubmed/32443346
http://dx.doi.org/10.1097/MD.0000000000020211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253538/
https://www.ncbi.nlm.nih.gov/pubmed/32443346
http://dx.doi.org/10.1097/MD.0000000000020211

Ejemplares similares